Literature DB >> 21977997

Transient modification within a pool of CD4 T cells in the maternal spleen.

Elizabeth A Bonney1, Michelle T Shepard, Peyman Bizargity.   

Abstract

Classic models suggest maternal tolerance is dependent on regulation of fetal antigen-specific T cell responses. We hypothesize that factors unique to a particular fetal antigen-specific T cell, rather than the state of pregnancy per se, are important determinants of T cell fate during pregnancy. To investigate the fate of fetal antigen-specific CD4 T cells in the systemic circulation, we examined spleen cells in a CD4 T cell receptor transgenic mouse specific for the male antigen H-Y. We observed a transient decrease in CD4(+) Vβ6(+) cell numbers and, due to transient internalization of CD4, an increase in CD4(-) Vβ6(+) T cells. Antigen-specific in vitro responsiveness was not depressed by pregnancy. These data suggest that pregnancy supports fluidity in this particular CD4 T cell pool that may, in turn, help to meet competing requirements of maternal immune responsiveness and fetal tolerance.
© 2011 The Authors. Immunology © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21977997      PMCID: PMC3209567          DOI: 10.1111/j.1365-2567.2011.03486.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  42 in total

1.  Paternal antigen-bearing cells transferred during insemination do not stimulate anti-paternal CD8+ T cells: role of estradiol in locally inhibiting CD8+ T cell responses.

Authors:  Matthew M Seavey; Tim R Mosmann
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

2.  Runx1 binds positive transcription elongation factor b and represses transcriptional elongation by RNA polymerase II: possible mechanism of CD4 silencing.

Authors:  Huimin Jiang; Fan Zhang; Takeshi Kurosu; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

3.  CD4+ CD25+ regulatory T cells in human pregnancy: development of a Treg-MLC-ELISPOT suppression assay and indications of paternal specific Tregs.

Authors:  Jenny Mjösberg; Göran Berg; Jan Ernerudh; Christina Ekerfelt
Journal:  Immunology       Date:  2007-01-11       Impact factor: 7.397

4.  Mechanisms of action of regulatory T cells specific for paternal antigens during pregnancy.

Authors:  Anne Schumacher; Paul O Wafula; Annarosa Zambon Bertoja; André Sollwedel; Catharina Thuere; Ivonne Wollenberg; Hideo Yagita; Hans-Dieter Volk; Ana Claudia Zenclussen
Journal:  Obstet Gynecol       Date:  2007-11       Impact factor: 7.661

5.  Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus.

Authors:  Adrian Erlebacher; Daniela Vencato; Kelly A Price; Dorothy Zhang; Laurie H Glimcher
Journal:  J Clin Invest       Date:  2007-04-19       Impact factor: 14.808

6.  Normal establishment of virus-specific memory CD8 T cell pool following primary infection during pregnancy.

Authors:  Carolyn M Constantin; David Masopust; Tania Gourley; Jason Grayson; Ora L Strickland; Rafi Ahmed; Elizabeth A Bonney
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

Review 7.  Preeclampsia: a view through the danger model.

Authors:  Elizabeth A Bonney
Journal:  J Reprod Immunol       Date:  2007-05-04       Impact factor: 4.054

8.  Fetal expression of Fas ligand is necessary and sufficient for induction of CD8 T cell tolerance to the fetal antigen H-Y during pregnancy.

Authors:  Melanie S Vacchio; Richard J Hodes
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

9.  Alloantigen-enhanced accumulation of CCR5+ 'effector' regulatory T cells in the gravid uterus.

Authors:  Marinos Kallikourdis; Kristian G Andersen; Katie A Welch; Alexander G Betz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-29       Impact factor: 11.205

10.  Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation.

Authors:  Zhengguo Xiao; Matthew F Mescher; Stephen C Jameson
Journal:  J Exp Med       Date:  2007-10-22       Impact factor: 14.307

View more
  7 in total

1.  Impact of Immune Deficiency on Remodeling of Maternal Resistance Vasculature 4 Weeks Postpartum in Mice.

Authors:  Elizabeth A Bonney; Ann Howard; Kendall Krebs; Kelly Begin; Kelsey Veilleux; Natalia I Gokina
Journal:  Reprod Sci       Date:  2017-01-19       Impact factor: 3.060

2.  Effector and Activated T Cells Induce Preterm Labor and Birth That Is Prevented by Treatment with Progesterone.

Authors:  Marcia Arenas-Hernandez; Roberto Romero; Yi Xu; Bogdan Panaitescu; Valeria Garcia-Flores; Derek Miller; Hyunyoung Ahn; Bogdan Done; Sonia S Hassan; Chaur-Dong Hsu; Adi L Tarca; Carmen Sanchez-Torres; Nardhy Gomez-Lopez
Journal:  J Immunol       Date:  2019-03-27       Impact factor: 5.422

3.  Demystifying animal models of adverse pregnancy outcomes: touching bench and bedside.

Authors:  Elizabeth A Bonney
Journal:  Am J Reprod Immunol       Date:  2013-02-28       Impact factor: 3.886

Review 4.  To drive or be driven: the path of a mouse model of recurrent pregnancy loss.

Authors:  Elizabeth A Bonney; Stephen A Brown
Journal:  Reproduction       Date:  2014-04-08       Impact factor: 3.906

5.  PD-1 regulates T cell proliferation in a tissue and subset-specific manner during normal mouse pregnancy.

Authors:  Michelle T Shepard; Elizabeth A Bonney
Journal:  Immunol Invest       Date:  2013-06-19       Impact factor: 3.657

6.  The Cellular Transcriptome in the Maternal Circulation During Normal Pregnancy: A Longitudinal Study.

Authors:  Nardhy Gomez-Lopez; Roberto Romero; Sonia S Hassan; Gaurav Bhatti; Stanley M Berry; Juan Pedro Kusanovic; Percy Pacora; Adi L Tarca
Journal:  Front Immunol       Date:  2019-12-17       Impact factor: 7.561

7.  Deficiency in CD4 T Cells Leads to Enhanced Postpartum Internal Carotid Artery Vasoconstriction in Mice: The Role of Nitric Oxide.

Authors:  Natalia I Gokina; Rebecca I Fairchild; Kirtika Prakash; Nicole M DeLance; Elizabeth A Bonney
Journal:  Front Physiol       Date:  2021-06-16       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.